Unlock instant, AI-driven research and patent intelligence for your innovation.

Pyrimidocyclic compound and its preparation method and application

A technology of cyclic compounds and compounds, applied in the field of salts and their solvates, and pyrimidocyclic compounds, which can solve the problem of low inhibitory activity of tumor cells

Active Publication Date: 2022-06-03
青煜医药研发(上海)有限公司
View PDF16 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned patents disclose allosteric inhibition, but most of them have low inhibitory activity on tumor cells, such as the compound SHP099 (6-(4-amino-4-methylpiperidin-1-yl) disclosed in WO 2015 / 107493 A1 )-3-(2,3-dichlorophenyl)pyrazin-2-amine), etc., need to further develop SHP2 inhibitors with novel structure, good biological activity and high druggability

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrimidocyclic compound and its preparation method and application
  • Pyrimidocyclic compound and its preparation method and application
  • Pyrimidocyclic compound and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0211] Example 1: Preparation of intermediate 5-chloro-8-((2,3-dichlorophenyl)thio)imidazo[1,2-c]pyrimidine (B1)

[0212] Step 1: 2-Chloro-N-(2,2-dimethoxyethyl)-5-iodopyrimidin-4-amine

[0213]

[0214] To a dry 2 L flask was added 2,4-dichloro-5-iodopyrimidine (110 g, 400 mmol) followed by 2,2-dimethoxyethylamine (84 g, 800 mmol) and absolute ethanol (1.2 L). Under nitrogen at 0°C, triethylamine (109 mL, 800 mmol) was slowly added dropwise thereto, and the mixture was stirred at room temperature to react for 10 hours. After the reaction was completed, concentrated in vacuo, the obtained concentrate was added with 1 L of water, extracted with dichloromethane (3×300 mL), washed with saturated brine, and the organic layers were mixed, dried over anhydrous sodium sulfate, filtered and concentrated to obtain The brown-black solid was washed with absolute ethanol (3×50 mL) to give a brown solid 2-chloro-N-(2,2-dimethoxyethyl)-5-iodopyrimidin-4-amine (110 g, yield: 78%).

[0...

Embodiment 2

[0228] Example 2: Preparation of intermediate 5-chloro-8-iodoimidazo[1,2-c]pyrimidine (E1)

[0229]

[0230]Into a dry 250mL single-necked flask were added 8-iodoimidazo[1,2-c]pyrimidin-5-ol (5g, 19.1mmol) and phosphorus oxychloride (50mL) in turn, under the protection of nitrogen, slowly added N , N-diisopropylethylamine (1 mL), after which the mixture was heated to 120°C and stirred for 4 hours. After the completion of the reaction, the reaction solution was cooled to room temperature and concentrated in vacuo, then quenched by adding saturated sodium bicarbonate solution, extracted with ethyl acetate (3×100 mL), the organic layers were mixed and washed with saturated brine, washed with anhydrous sodium sulfate Dried, filtered and concentrated, and purified by column chromatography to give the resulting residue was purified by silica gel chromatography (0 to 10% gradient of methanol:ethyl acetate) to give 5-chloro-8-iodoimidazo[1,2- c] Pyrimidine El (1.6 g, yield: 29.8%)...

Embodiment 3

[0232] Example 3: Intermediate (R)-2-methyl-N-((R)-8-azaspiro[4.5]decan-1-yl)propane-2-sulfinamide (C-1A) preparation

[0233] Step 1: (R)-1-((R)-1,1-dimethylethylsulfinamido)-8-azaspiro[4.5]decane-8-carboxylic acid tert-butyl ester

[0234]

[0235] In a dry 100mL single-necked flask were sequentially added tert-butyl 1-carbonyl-8-azaspiro[4.5]decane-8-carboxylate (2.53g, 10mmol), tetraethoxytitanium (6.84g, 30mmol) and 50 mL of tetrahydrofuran, and the reaction was stirred under reflux for 4 hours. After cooling to room temperature, methanol (10 mL) was added followed by lithium borohydride (0.65 g, 30 mmol). The resulting mixture was stirred at room temperature for 3 hours. Methanol was added slowly to quench excess borohydride, followed by brine. The resulting mixture was stirred for 15 minutes and then filtered through celite. The aqueous mixture was extracted with ethyl acetate (3 x 50 mL). The organic phase was MgSO 4 Dry, filter, and remove volatiles under re...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses pyrimidocyclic compounds, pharmaceutically acceptable salts and solvates thereof. The invention also provides the preparation method of the compound, the composition containing the compound and the use of the compound in the preparation of medicines for treating diseases or diseases related to abnormal SHP2 activity.

Description

technical field [0001] The present invention discloses pyrimidocyclic compounds, pharmaceutically acceptable salts and solvates thereof. The present invention also provides a preparation method of the compound, a composition containing the compound and the use of the compound in the preparation of a medicine for treating diseases or conditions related to abnormal SHP2 activity. Background technique [0002] The tyrosine phosphatase SHP2 consists of two N-terminal Src homology 2 domains (N-SH2 and C-SH2) and a protein tyrosine phosphatase catalytic domain (PTP). In the basal state, N-SH2 can combine with PTP to form a ring structure, thereby hindering the binding of PTP to the substrate, so that the catalytic activity of the enzyme is inhibited; when the tyrosine of the upstream receptor protein is phosphorylated, N-SH2 When SH2 binds to it, the PTP catalytic domain is released to exert phosphatase activity. [0003] At the cellular level, SHP2 participates in multiple tumo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D487/04C07D519/00A61K31/519A61K31/55A61K45/06A61P35/02A61P35/00
CPCC07D487/04C07D519/00A61K45/06C07D221/20C07D209/96C07D223/12C07D491/107C07D211/26C07D213/75C07D213/73C07D213/70C07D215/36C07D277/62C07D277/36C07D235/06C07D471/04C07D307/79A61P35/00A61P35/02A61K31/519A61K31/55C07B2200/07A61K2300/00
Inventor 邹斌张睿付贤磊马世超
Owner 青煜医药研发(上海)有限公司